PLENARY SESSION // POSTER FLASH SESSION

14:30 • S12L1 • A CRISPR-based mouse model of TPM3-related Congenital Fiber Type Disproportion (CFTD) recapitulates key features of the disease. > M. Matthias LAMBERT (Boston, Usa) 14:33 • S12L2 • ME/CFS and Long COVID-19 Patient Sera induce Hypermetabolism while Impairing Contractile Force in a 3-D Model of Human Skeletal Muscle > S. Sheeza MUGHAL (Barcelona, Spain) 14:39 • S12L4 • Lost In Translation: Pathogenic translation of GGC repeats in novel and toxic proteins in Oculo-Pharyngo-Distal Myopathy (OPDM) > M. Manon BOIVIN (Illkirch, France) 14:42 • S12L5 • RyR1 content decrease-induced ER stress is a hallmark of myopathies > N. Nadège ZANOU (Lausanne) 14:45 • S12L6 • Elucidating CHCHD10 Mutant Phenotypes in Inducible Cell Models and Designing Effective Therapeutic Strategies > C. Christian LANTZ (Atglen, Pennsylvania, Usa) 14:48 • S12L7 • PHF2 demethylase controls muscle stem cell fate modulating lipid droplets turnover > D. Delia CICCIARELLO (Lyon) 14:51 • S12L8 • Study of the role of muscle metabolism in Amyotrophic Lateral Sclerosis > F. Flore CHEGUILLAUME (Paris, France) 14:54 • S12L9 • Activation of the WNT-dependent fibrogenic program by C1s/r complement subunits in dystrophic muscle > S. Stefano BIRESSI (Trento, Italy) 14:57 • S12L10 • Muscle contributions to flunarizine-mediated beneficial effects in spinal muscular atrophy > S. Suzie LEFEBVRE (Paris, France) 15:00 • S12L11 • Imaging of muscle perfusion of dystrophic mice in situ with laser-speckle contrast analysis > L. Laurence NEFF (Geneva, Switzerland) 15:03 • S12L12 • Patients with Myotonic Dystrophy and GCC interruptions manifest late disease onset, greater proximal weakness, but similar neuromuscular, cardiac and CNS involvement as patients without interruptions > G. Gisela NOGALES GADEA (Barcelona, Spain) 15:06 • S12L13 • Live imaging reveals perturbed symmetric stem cell divisions in a mouse model of Duchenne Muscular Dystrophy > B. Brendan EVANO (Paris, France) 15:09 • S12L14 • Spatial restriction of dystrophin in skeletal muscle – implications for therapeutic interventions. > K. Katarzyna CHWALENIA (Oxford, Uk) 15:12 • S12L15 • GDF5 overexpression improves pathophysiology of DMD in mdx mouse muscle > C. Christel GENTIL (Paris, France)